-
Six Patient Engagement “Trends” We Should Have Outgrown by 2026
By Cheryl Lubbert, Reverba Global CEO. A New-Year Perspective on Patient Engagement The biopharma industry talks a good game about patient engagement. We talk about personalization, digital transformation, empowerment, omnichannel…
-
Elevating Voices, Empowering Futures: Mentorship as a Catalyst for Change in Biopharma
By Cheryl Lubbert, Reverba Global CEO. In biopharma, where innovation depends on both scientific discovery and human connection, mentorship stands as one of the most powerful forces for progress. It’s…
-
Bridging Science and Strategy: Medical Affairs at the Heart of Omnichannel Engagement
In this video podcast hosted by Pharmaphorum, Editor in Chief Jonah Comstock speaks with Cheryl Lubbert, co-founder and CEO of Reverba Global, and Carolyn Whiting, SVP of Clinical and Medical…
-
Turning Data into Dialogue: How Numbers Build Trust Between Patients and Clinicians
By Cheryl Lubbert, CEO of Reverba Global In healthcare, every word matters – but the way we communicate those words, and the numbers behind them, is changing. For patients to…
-
Closing the Gap: Why Patient Engagement Can’t Wait
Key Takeaways For all the progress in modern healthcare—from electronic records to AI-driven insights—a critical question remains: Why do so many people still feel unheard in their own care? Innovation…
-
Highlights from HBA: Collaboration Is the New Competitive Advantage
At this year’s Healthcare Businesswomen’s Association (HBA) Annual Conference, one message resonated across every room: no one can tackle systemic inequities alone. And this conference provides tools to work together…
-
Beyond the Algorithm: What HLTH 2025 Showed Us About the Future of Human-Centered Innovation
The pulse of HLTH 2025 At this year’s HLTH USA conference in Las Vegas, the conversation was louder—and more human—than ever. Thousands of leaders from pharma, biotech, technology, and care…
-
Reverba Global Introduces ClinOps G.P.S.™ to Set a New Course for Clinical Trial Execution and Chart a Clearer Path from Protocol to Completion
Comprehensive clinical operations navigation system aligns sponsors, CROs, investigators, sites and patients to improve trial planning, performance and outcomes Implementation with a top 15 global pharmaceutical company demonstratedmeasurable and significant…
-
Reverba Unveils Updated Brand Identity as Reverba Global™, Reflecting the Company’s Expansion and Global Capabilities as a Leader in Healthcare Engagement
Seattle, WA – April 07, 2025 – Reverba, a leader in healthcare engagement, today announced its rebranding as Reverba Global in response to accelerated company growth and international scope. At…
-
Change ROI to IOR: Measuring the Impact of Relationships with Patients
As we work to help biopharmaceutical and healthcare companies integrate the voice of the patient and transform their organizations by embracing patient engagement, we often hear a familiar question: “What…
-
Reverba selected as a Gold Winner in the 2024 TITAN Business Awards.
The TITAN Business Awards recognize the achievements, leadership and innovation of organizations worldwide that are driving industries forward. Seattle, WA – November 15, 2024 – Reverba, a global health engagement…
-
Listen to our CEO on: Patient Engagement Throughout the Product Lifecycle
Key considerations for effective patient engagement throughout the product lifecycle and clinical trials, and how to leverage this engagement as the industry moves forward Watch this thought-provoking video discussion as…
